Journal Article Summary

The article investigates the effects of Zishen Yutai Pill (ZYP), a traditional Chinese medicine, on improving ovarian reserve in models of diminished ovarian reserve (DOR), a condition that significantly contributes to female infertility. DOR is characterized by a reduced quantity and quality of oocytes, which can be influenced by factors such as age and environmental stressors. Given the rising incidence of DOR, especially among younger women, understanding effective treatments is crucial for enhancing fertility options and outcomes.

In this study, researchers used two animal models—a rat model induced by tripterygium glycosides and a mouse model induced by pZP3—to evaluate the therapeutic effects of ZYP over a four-week period. The results showed that ZYP administration significantly increased the number of primordial follicles and serum levels of anti-Müllerian hormone (AMH), a key marker of ovarian reserve. Additionally, ZYP appeared to regulate the apoptosis pathway in the ovaries, reducing cell death in a dose-dependent manner, which suggests that it may help preserve ovarian function.

However, the study has limitations, including the need for further exploration of the complex mechanisms by which ZYP operates and the necessity for larger clinical trials to confirm its efficacy in diverse populations. Patients considering ZYP for DOR should discuss its use with a healthcare professional, especially since traditional Chinese medicine often requires individualized treatment approaches. Understanding the potential benefits and risks, as well as how ZYP fits into a broader treatment plan, is essential for informed decision-making regarding fertility treatments.

Medication Safety Note

This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication. Always consult a licensed healthcare professional before using a medical device.

Article Cited

  1. Chen Jianzhao, Wang Nannan, Peng Zilun, Pang Xiufei, Ning Na, Du Qingyun, Guo Qiuping, Huang Qiuling. Zishen Yutai pill ameliorates ovarian reserve by mediating PI3K-Akt pathway and apoptosis level in ovary. Journal of Ovarian Research 2025. DOI: 10.1186/s13048-025-01643-0. PMID: 40128862. PMCID: PMC11931746.

Featured Pill Pals Product

Pill Pals® is THE Express Pharmacy. Our Nationwide Pharmacy Network was created with the mission of helping you make SENSE of your meds™. As a Pharmacy Benefits Management organization, Pill Pals® gives patients the best cash prices on all meds. Pill Pals® is part of The Health Pals® Company (Health Pals®, Med Pals®, Skin Pals® etc), a vertically integrated Healthcare System that provides cost effective Medical and Pharmacy services to Employers, Patients, and more. For more information, please email [email protected]